Who makes Sclerosing foam of Lauromacrogol?

Sclerosing foam of Lauromacrogol is developed by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.

What development phase is Sclerosing foam of Lauromacrogol in?

Sclerosing foam of Lauromacrogol is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · FDA-approved active Small molecule Quality 3/100

Generic name	Sclerosing foam of Lauromacrogol
Sponsor	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Modality	Small molecule
Phase	FDA-approved

No approved indications tracked.

No common side effects on file.

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results